ARTC Insider Trading Activity and SEC Form 4 Filings
ARTC insider trading summary
No open-market insider purchases or sales of Arthrocare Corp (ARTC) have been reported on SEC Form 4 in the past 12 months.
Latest ARTC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 3, 2014 | Bruce Prothro | Chief Regulatory Officer & SVP | Sell | $169K (3,474 @ $48.59) |
| Jan 9, 2014 | Jean Woloszko | Chief Tech Officer & SVP R&D | Sell | $44K (961 @ $46.04) |
| Jan 9, 2014 | Jean Woloszko | Chief Tech Officer & SVP R&D | Sell | $34K (735 @ $46.04) |
| Jan 8, 2014 | Jean Woloszko | Chief Tech Officer & SVP R&D | Sell | $93K (2,000 @ $46.50) |
| Jan 8, 2014 | Jean Woloszko | Chief Tech Officer & SVP R&D | Sell | $130K (2,801 @ $46.50) |
| Jan 8, 2014 | Jean Woloszko | Chief Tech Officer & SVP R&D | Sell | $267K (5,929 @ $44.95) |
| Jan 8, 2014 | Jean Woloszko | Chief Tech Officer & SVP R&D | Sell | $201K (4,478 @ $44.95) |
| Jan 8, 2014 | Bruce Prothro | Chief Regulatory Officer & SVP | Sell | $124K (2,646 @ $47.00) |
| Jan 8, 2014 | Jean Woloszko | Chief Tech Officer & SVP R&D | Sell | $338K (7,270 @ $46.50) |
| Jan 8, 2014 | Bruce Prothro | Chief Regulatory Officer & SVP | Sell | $1.0M (22,136 @ $46.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.